ADC 1779
Alternative Names: ADC-1779Latest Information Update: 23 Dec 2022
At a glance
- Originator ADIENNE
- Class Antineoplastics; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Haematological malignancies; Precursor T-cell lymphoblastic leukaemia-lymphoma
Most Recent Events
- 08 Dec 2022 Early research in Haematological malignancies in Switzerland (Parenteral) (Adienne pipeline, December 2022)
- 08 Dec 2022 Early research in Precursor T-cell lymphoblastic leukaemia-lymphoma in Switzerland (Parenteral) (Adienne pipeline, December 2022)